photo of

Details

Role Group Leader
Group SAEFVIC

Contact

Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the...
Professor Crawford is a consultant paediatrician and vaccinologist, he is also recognised as an expert in vaccination of special risk groups. He is the Director of SAEFVIC (Surveillance of Adverse Events Following Vaccination In the Community) the Victorian Safety Service and the Melbourne Vaccine Education Centre (MVEC) where he leads a team of more than 30 staff members. Prof Crawford is Head of Immunisation Services at The Royal Children’s Hospital (RCH) and Chair of the Victorian Specialist Immunisation Services (VicSIS).

In 2021, Prof Crawford was appointed the Chair of the Australian Therapeutic Advisory Group on Immunisation (ATAGI), Ex-officio Member of COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group (SITAG), Member of Department of Foreign Affairs and Trade (DFAT) COVID-19 vaccine Expert Advisory Group (EAG), Member of the Victorian Department of Health, COVID-19 vaccine Expert Advisory Group (EAG), member of Vaccination Special Interest Group (VACSIG)/ Australasian Society for Infectious Diseases (ASID), and the Victorian representative of TGA-JIC (Jurisdictional Immunisation Co-ordinators) vaccine safety meetings with Australian Government Department of Health. Internationally, Prof Crawford is the founding/steering committee member of the International Specialist Immunisation Services (InSIS) network in Canada, a member of the World Health Organisation (WHO), Geneva and most recently appointed as the WPRO (Western Pacific Region) Representative of the GNN (Global NITAG Network) steering committee in WHO Geneva.

Top Publications

  • Tosif, S, Haycroft, ER, Sarkar, S, Toh, ZQ, Ha, LA, Donato, CM, Selva, KJ, Hoq, M, Overmars, I, Nguyen, J, et al. Virology and immune dynamics reveal high household transmission of ancestral SARS‐CoV‐2 strain. Pediatric Allergy and Immunology 33(7) : 10.1111/pai.13824 2022
    view publication
  • Toh, ZQ, Higgins, RA, Anderson, J, Mazarakis, N, Ha, LA, Rautenbacher, K, Ramos, P, Dohle, K, Tosif, S, Crawford, N, et al. The use of dried blood spots for the serological evaluation of SARS-CoV-2 antibodies. Journal of Public Health 44(2) : fdab011 2022
    view publication
  • Crawford, NW. Importance of understanding the reinfection risk of COVID-19 in children. The Lancet Child & Adolescent Health 6(6) : 355 -357 2022
    view publication
  • Gunaratna, GPS, Mohammad, SS, Blyth, CC, Clark, J, Crawford, N, Marshall, H, Dale, RC, Jones, CA, Britton, PN, network, OBOTP. Postinfectious Acute Cerebellar Syndromes in Children: A Nationally Ascertained Case Series From Australia 2013–2018. Journal of Child Neurology 37(7) : 617 -623 2022
    view publication
  • Cheng, DR, Clothier, HJ, Morgan, HJ, Roney, E, Shenton, P, Cox, N, Jones, BO, Schrader, S, Crawford, NW, Buttery, JP, et al. Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia. BMJ Paediatrics Open 6(1) : e001472 2022
    view publication

Page 16 of 44